Cannabinoid CB(2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells.
about
The CB2-preferring agonist JWH015 also potently and efficaciously activates CB1 in autaptic hippocampal neuronsInhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future AntidepressantsThe Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.Mu-opioid receptor and delta-opioid receptor differentially regulate microglial inflammatory response to control proopiomelanocortin neuronal apoptosis in the hypothalamus: effects of neonatal alcohol.CB2 receptor activation inhibits melanoma cell transmigration through the blood-brain barrier.Involvement of neuronal TGF-β activated kinase 1 in the development of tolerance to morphine-induced antinociception in rat spinal cord.Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions.Neuroinflammation as a possible link between cannabinoids and addiction.The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain.Delay of morphine tolerance by palmitoylethanolamide.Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists.The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.Slowly Signaling G Protein-Biased CB2 Cannabinoid Receptor Agonist LY2828360 Suppresses Neuropathic Pain with Sustained Efficacy and Attenuates Morphine Tolerance and Dependence.Activation of cannabinoid receptor 2 attenuates mechanical allodynia and neuroinflammatory responses in a chronic post-ischemic pain model of complex regional pain syndrome type I in rats.
P2860
Q24602152-BB749C36-822C-4AA4-B7A4-C1CAEB6AB112Q28082891-52A7C9DE-08E6-435F-8136-429231B961C8Q30733453-855247CE-E6FB-40C6-8152-8BDB8478DDF7Q33564639-D72134BB-3B25-4D87-A370-D1B871D7B5CBQ33755702-9911B922-FA5A-4D64-B5FA-77C3D8942B97Q35631488-69D48DB5-B01D-4B5B-8DA6-8C7E8DA42EA1Q38185071-274B1BCD-FFAA-4448-B65D-8A1C31A83148Q38278954-A7A28F60-217A-40D1-901C-D33FEA543A27Q38600704-236CA2AC-325B-400D-AA44-2AA37D9C1EB6Q41665044-86C0BBBC-DFB9-4655-8D6C-59D735CD8139Q41908176-89325543-1181-4765-8056-DB42E1EF3000Q44342190-C2BB6552-1E18-404C-B50F-60D432ABECD5Q45047828-3D57F13F-A1BC-4B6F-8100-F0ECE4E63ED2Q47344641-1275EF77-90B9-4DF2-A1C4-1FB67B0945FCQ51417508-021A254E-4DAF-4CDA-88C8-66B4A448BF90
P2860
Cannabinoid CB(2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cannabinoid CB(2) receptor at ...... in activated microglial cells.
@en
type
label
Cannabinoid CB(2) receptor at ...... in activated microglial cells.
@en
prefLabel
Cannabinoid CB(2) receptor at ...... in activated microglial cells.
@en
P2093
P2860
P921
P1476
Cannabinoid CB(2) receptor at ...... in activated microglial cells.
@en
P2093
Debora Fazzi
Katia Varani
Pier Andrea Borea
Stefania Gessi
Stefania Merighi
P2860
P304
P356
10.1111/J.1476-5381.2012.01948.X
P407
P577
2012-08-01T00:00:00Z